[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"consent-forms\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:consent-forms":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,49],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":20,"enrollmentInfo":21,"targetDuration":4,"studyType":24,"phases":25,"briefSummary":27,"conditions":28,"keywords":32,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":38,"lastUpdatePostDateStruct":39,"startDateStruct":42,"completionDateStruct":44,"leadSponsor":46,"locationsCount":5},"100589057","effectiveness-of-large-language-model-for-anaesthesia-and-procedural-consent-100589057",false,"NCT06949462","Effectiveness of Large Language Model for Anaesthesia and Procedural Consent","Evaluating the Effectiveness of Large Language Models in Anaesthesia and Procedural Consent: A Comparative Analysis With Traditional Patient Consent Methods","PEAR","Inclusion Criteria:\n\n\\- Adults (≥21 years old) undergoing elective surgery requiring anaesthesia\n\nClassified as ASA Physical Status I to III\n\n* Able to provide informed consent\n* Able to communicate effectively in English, Chinese (Mandarin), Malay, or Tamil\n* Willing and able to complete questionnaires and interact with the PEAR chatbot (intervention arm)\n\nExclusion Criteria:\n\n* ASA Physical Status IV or above\n* Cognitive impairment or psychiatric conditions that may limit comprehension or communication\n* Non-literate patients or those unable to understand English, Chinese, Malay, or Tamil\n* Emergency surgery cases\n* Prior participation in the study (to prevent bias)",true,"ALL","21 Years","99 Years",{"count":22,"type":23},120,"ESTIMATED","INTERVENTIONAL",[26],"NA","Patient understanding of anaesthesia risks remains inconsistent due to time constraints, language barriers, and variable clinician communication styles. Traditional verbal consent may not consistently ensure comprehension or reduce preoperative anxiety. PEAR (Patient Education of Anesthesia Risks) is a multilingual, AI-driven chatbot developed to enhance patient education and improve the quality of anaesthesia risk counselling.\n\nStudy Objective:\n\nTo compare PEAR's performance in delivering anaesthesia risk consent against the standard face-to-face verbal method.",[29,30,31],"Consent Forms","Anesthesia","Artificial Intelligence (AI)",[33,34,35,36],"Anaesthesia","Informed Consent","Large Language Model","Artificial Intelligence","RECRUITING","2026-04-30",{"date":40,"type":41},"2026-05-07","ACTUAL",{"date":43,"type":41},"2026-01-07",{"date":45,"type":23},"2026-04-27",{"name":47,"class":48},"Singapore General Hospital","OTHER",{"id":50,"slug":51,"hasResults":11,"nctId":52,"briefTitle":53,"officialTitle":54,"acronym":55,"eligibilityCriteria":56,"healthyVolunteers":11,"sex":18,"minAge":57,"maxAge":58,"enrollmentInfo":59,"targetDuration":4,"studyType":24,"phases":61,"briefSummary":62,"conditions":63,"keywords":4,"overallStatus":37,"whyStopped":4,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":76},"100623934","post-market-clinical-follow-up-study-of-nemost-v2-100623934","NCT07403084","Post-market Clinical Follow-up Study of NEMOST V2","Post-market Clinical Follow-up Study of NEMOST V2 Growing Domino","NEMOST V2","Inclusion Criteria:\n\n* Idiopathic, congenital, neuromuscular, or syndromic scoliosis : Progressive spinal deformity not managed by orthopedic treatment, and requiring primary surgical intervention.\n* The patient, as well as their parents or legal guardians, are informed of the participation in the study.\n* Patients aged from 5 to 17 yeas old, excepted the one who still have a potential for growth\n\nExclusion Criteria:\n\n* signs of local inflammation;\n* acute or chronic, local or systemic infections ;\n* non-reducible scoliosis ;\n* pathological obesity ;\n* allergy or intolerance to implanted materials;\n* insufficiency or absence of tissue coverage. The NEMOST implant should not be used in a spine that has already been instrumented or fused.","5 Years","17 Years",{"count":60,"type":23},140,[26],"The NEMOST spinal implant is a growth domino intended for the surgical treatment of progressive scoliosis in children.\n\nAs part of post-market surveillance, EUROS is conducting a retrospective and prospective study to collect clinical and radiological data on the NEMOST growth domino.\n\nRetrospective and prospective multicenter post-market surveillance clinical study.\n\nThis study is interventional, non-randomized, and uncontrolled. The primary objective of this clinical study is to monitor complications related to the NEMOST growth domino during a 5-year postoperative follow-up in patients treated for progressive scoliosis in children.\n\nThe secondary objective of this clinical study is to monitor the performance of the NEMOST growth domino during a 5-year postoperative follow-up in patients treated for progressive scoliosis in children.\n\nThe study will include 140 patients.",[64,65,29],"Scoliosis Neuromuscular","Scoliosis Idiopathic","2026-02-04",{"date":68,"type":41},"2026-02-11",{"date":70,"type":41},"2025-12-19",{"date":72,"type":23},"2033-12-19",{"name":74,"class":75},"EUROS","INDUSTRY",5]